Medical Marijuana: Evidence-Based Assessment of Efficacy and Harms
| thcscout | Medical | No Comments on Medical Marijuana: Evidence-Based Assessment of Efficacy and Harms
Share
- No bookmark found
www.massmed.org | Alan Ehrlich, MD, assistant professor of family medicine at the University of Massachusetts Medical School, discusses the evidence of the efficacy and harms of medical marijuana.
His presentation focuses the use of medical marijuana for such conditions as glaucoma, multiple sclerosis, Crohn’s disease, HIV related disorders, ALS, and epilepsy. His presentation was part of the Massachusetts Medical Society’s CME program in June 2014, “Medical Marijuana: Regulations, Responsibilities and Communication.”
His presentation focuses the use of medical marijuana for such conditions as glaucoma, multiple sclerosis, Crohn’s disease, HIV related disorders, ALS, and epilepsy. His presentation was part of the Massachusetts Medical Society’s CME program in June 2014, “Medical Marijuana: Regulations, Responsibilities and Communication.”